Skybiotech Healthcare Q2 FY27 Results: Net Loss of ₹0.8 Cr, Loss Widens
Skybiotech Healthcare Ltd reported revenue from operations of ₹1 Cr (-47.4% YoY) and a net loss of ₹0.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.8 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Skybiotech Healthcare Ltd reported revenue from operations of ₹1 Cr (-47.4% YoY) and a net loss of ₹0.8 Cr for Q2 FY27.
Skybiotech Healthcare Ltd has scheduled a board meeting for November 10, 2026. The board will consider unaudited financial results for the quarter ended September 30, 2026.
This is a routine quarterly shareholding pattern filing for Skybiotech Healthcare Ltd in compliance with SEBI Regulation 31(1)(b).
Skybiotech Healthcare Limited held its 43rd Annual General Meeting on September 30, 2026. Shareholders approved audited financial statements, director re-appointment, and the appointment of statutory auditors.
Skybiotech Healthcare Ltd has issued the notice for its 43rd Annual General Meeting. The meeting is scheduled to be held on September 30, 2026.
Skybiotech Healthcare Ltd has filed its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
Skybiotech Healthcare Ltd reported revenue from operations of ₹0.5 Cr (-79.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.